PMID- 35605535 OWN - NLM STAT- MEDLINE DCOM- 20220617 LR - 20220922 IS - 1879-0046 (Electronic) IS - 0376-8716 (Linking) VI - 236 DP - 2022 Jul 1 TI - Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the U.S., 2015-2018. PG - 109498 LID - S0376-8716(22)00235-6 [pii] LID - 10.1016/j.drugalcdep.2022.109498 [doi] AB - AIMS: To examine the use and association of medications for opioid use disorder (MOUD) with treatment completion and retention for criminal justice referred (CJR) admissions to residential treatment. METHODS: A retrospective analysis of the Treatment Episode Dataset-Discharge (TEDS-D; 2015-2018) for adults (N = 205,348) admitted to short-term (ST) (< 30 days) or long-term (LT) (>30 days) residential treatment for OUD. Outcomes were MOUD in treatment plans, and treatment completion and retention (ST >10 days; LT > 90 days). Logistic regression analyses were conducted separately for ST and LT settings. RESULTS: CJR admissions were less likely to have MOUD than non-CJR admissions (ST, 11% vs. 21%; LT, 10% vs. 24%, respectively) and were more likely to complete and be retained in treatment. In ST settings, MOUD was associated with higher likelihood of treatment completion and retention. In LT settings, MOUD was associated with higher likelihood of treatment retention and lower likelihood of treatment completion. These associations tended to be slightly weaker for CJR admissions, with the exception of treatment completion in LT settings, but the moderating effect size of CJR status in all models was very small. Small differences in the moderating effect of CJR status by race and ethnicity were observed in LT settings. CONCLUSIONS: MOUD is greatly under-utilized for CJR patients, and given that MOUD was associated with positive outcomes, there is a critical need to find ways to increase access to MOUD for CJR patients in residential treatment. Race and ethnicity appear to have relatively little impact on outcomes. CI - Copyright (c) 2022 Elsevier B.V. All rights reserved. FAU - Stahler, Gerald J AU - Stahler GJ AD - Department of Geography and Urban Studies, Temple University, United States. Electronic address: jstahler@temple.edu. FAU - Mennis, Jeremy AU - Mennis J AD - Department of Geography and Urban Studies, Temple University, United States. FAU - Stein, L A R AU - Stein LAR AD - Center for Alcohol & Addiction Studies, Brown University School of Public Health, United States; Department of Psychology, The University of Rhode Island, United States. FAU - Belenko, Steven AU - Belenko S AD - Department of Criminal Justice, Temple University, United States. FAU - Rohsenow, Damaris J AU - Rohsenow DJ AD - Center for Alcohol & Addiction Studies, Brown University School of Public Health, United States. FAU - Grunwald, Heidi E AU - Grunwald HE AD - Institute for Survey Research, Temple University, United States. FAU - Brinkley-Rubinstein, Lauren AU - Brinkley-Rubinstein L AD - Department of Social Medicine, University of North Carolina at Chapel Hill, United States. FAU - Martin, Rosemarie A AU - Martin RA AD - Center for Alcohol & Addiction Studies, Brown University School of Public Health, United States. LA - eng GR - U01 DA050442/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20220514 PL - Ireland TA - Drug Alcohol Depend JT - Drug and alcohol dependence JID - 7513587 RN - 0 (Analgesics, Opioid) RN - 40D3SCR4GZ (Buprenorphine) SB - IM MH - Adult MH - Analgesics, Opioid/therapeutic use MH - *Buprenorphine/therapeutic use MH - Criminal Law MH - Humans MH - Opiate Substitution Treatment MH - *Opioid-Related Disorders/drug therapy MH - Residential Treatment MH - Retrospective Studies MH - Treatment Outcome OTO - NOTNLM OT - Criminal justice OT - MOUD OT - Opioid use disorder OT - Residential treatment OT - Treatment completion OT - Treatment retention EDAT- 2022/05/24 06:00 MHDA- 2022/06/18 06:00 CRDT- 2022/05/23 18:29 PHST- 2022/02/01 00:00 [received] PHST- 2022/05/09 00:00 [revised] PHST- 2022/05/10 00:00 [accepted] PHST- 2022/05/24 06:00 [pubmed] PHST- 2022/06/18 06:00 [medline] PHST- 2022/05/23 18:29 [entrez] AID - S0376-8716(22)00235-6 [pii] AID - 10.1016/j.drugalcdep.2022.109498 [doi] PST - ppublish SO - Drug Alcohol Depend. 2022 Jul 1;236:109498. doi: 10.1016/j.drugalcdep.2022.109498. Epub 2022 May 14.